HomeCompareRDTCF vs ORCC

RDTCF vs ORCC: Dividend Comparison 2026

RDTCF yields 2222.22% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RDTCF wins by $26607504688.24M in total portfolio value
10 years
RDTCF
RDTCF
● Live price
2222.22%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26607504688.26M
Annual income
$24,443,703,761,807,280.00
Full RDTCF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — RDTCF vs ORCC

📍 RDTCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRDTCFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RDTCF + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RDTCF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RDTCF
Annual income on $10K today (after 15% tax)
$188,888.89/yr
After 10yr DRIP, annual income (after tax)
$20,777,148,197,536,188.00/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, RDTCF beats the other by $20,777,148,197,536,188.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RDTCF + ORCC for your $10,000?

RDTCF: 50%ORCC: 50%
100% ORCC50/50100% RDTCF
Portfolio after 10yr
$13303752344.14M
Annual income
$12,221,851,880,903,640.00/yr
Blended yield
91.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

RDTCF
No analyst data
Altman Z
-20.8
Piotroski
3/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RDTCF buys
0
ORCC buys
0
No recent congressional trades found for RDTCF or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRDTCFORCC
Forward yield2222.22%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$26607504688.26M$21.4K
Annual income after 10y$24,443,703,761,807,280.00$1.04
Total dividends collected$26455115546.17M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: RDTCF vs ORCC ($10,000, DRIP)

YearRDTCF PortfolioRDTCF Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$232,922$222,222.22$11,190$489.61+$221.7KRDTCF
2$5,086,656$4,837,429.33$12,229$256.01+$5.07MRDTCF
3$104,173,443$98,730,720.93$13,216$130.74+$104.16MRDTCF
4$2,001,166,924$1,889,701,340.37$14,207$66.02+$2001.15MRDTCF
5$36,067,485,611$33,926,237,001.88$15,234$33.17+$36067.47MRDTCF
6$610,050,404,477$571,458,194,873.63$16,317$16.62+$610050.39MRDTCF
7$9,686,139,336,337$9,033,385,403,546.24$17,468$8.32+$9686139.32MRDTCF
8$144,409,519,569,037$134,045,350,479,156.38$18,695$4.16+$144409519.55MRDTCF
9$2,022,243,856,495,371$1,867,725,670,556,501.50$20,006$2.08+$2022243856.48MRDTCF
10$26,607,504,688,257,330$24,443,703,761,807,280.00$21,407$1.04+$26607504688.24MRDTCF

RDTCF vs ORCC: Complete Analysis 2026

RDTCFStock

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes and quality of lives in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active ingredients into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system. The company also provides product innovation, production, and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries. It has a research partnership program with McMaster University for developing biopolymer compositions that can offer enhanced drug delivery performance when formulated in oral dissolvable thin films, as well as for developing orally delivered vaccine candidate for COVID-19. Rapid Dose Therapeutics Corp. is based in Burlington, Canada.

Full RDTCF Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this RDTCF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RDTCF vs SCHDRDTCF vs JEPIRDTCF vs ORDTCF vs KORDTCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.